150 related articles for article (PubMed ID: 6764120)
21. [The effect of levamisole on non-resected lung cancer--the results of randomized controlled study].
Nishimura M; Morishita M; Urata A; Ota K
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1981-93. PubMed ID: 6307178
[TBL] [Abstract][Full Text] [Related]
22. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
Fukushima M; Tsushima T; Ito H; Fukuda Y; Maruyama A; Fujita H; Yagihashi N; Tsuge T; Ishioka T; Kudo T; Kishibe S; Sato T; Machida S; Kogawa R; Takashima K; Koie H; Fujita K
Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823
[TBL] [Abstract][Full Text] [Related]
23. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
Liao ML; Zhou YZ; Ding JA; Ni GX; Zhao JM; Chen WH; Han BH; Shen J; Bai H; Chen ZW; Ji H; Wang HM; Zhou Z
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):962-6. PubMed ID: 12899797
[TBL] [Abstract][Full Text] [Related]
24. [Postoperative immunochemotherapy of gastric cancer using levamisole].
Hattori T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):380-6. PubMed ID: 6349537
[TBL] [Abstract][Full Text] [Related]
25. [Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer].
Yamamura Y; Yasue M; Kito T; Nakazato H; Yamada E
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1603-9. PubMed ID: 6409009
[TBL] [Abstract][Full Text] [Related]
26. [Relation between prognosis and the Su-PS skin reaction in patients with non-resected primary lung cancer receiving OK-432].
Nakarai I; Rikitake H; Koga T; Hayashi A; Harada Y; Takamoto M; Ishibashi T; Shinoda A; Sagawa K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3050-7. PubMed ID: 2823723
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432.
Watanabe Y; Iwa T
Cancer; 1984 Jan; 53(2):248-53. PubMed ID: 6690008
[TBL] [Abstract][Full Text] [Related]
28. [Phase III multi-center study of levamisole (LMS)--a randomized evaluation in advanced gastrointestinal cancer, with special reference to stomach cancer].
Wakui A; Kikuchi K; Yokoyama M; Takahashi K; Yoshida Y; Kaito I; Matsuoka T; Ishikawa M; Goto Y; Ono K; Kikkawa J; Sugahara K; Taima T
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1610-23. PubMed ID: 6347085
[TBL] [Abstract][Full Text] [Related]
29. [MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
Sakata Y; Yoshida Y; Komatsu Y; Sugawara K; Nishimura S; Kikuchi K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):109-15. PubMed ID: 6820875
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of postoperative immunochemotherapy in lung cancer].
Ikeda T; Sakai T; Suito T; Kosaki G
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1044-9. PubMed ID: 3008669
[TBL] [Abstract][Full Text] [Related]
31. [The clinical value of long-term administration of OK-432 in head and neck cancer].
Mitarai K; Tsukuda M; Tamamushi N; Mochimastu I; Kubota A; Sawaki S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):945-50. PubMed ID: 3963858
[TBL] [Abstract][Full Text] [Related]
32. [Studies on long-term intermittent immunochemotherapy of lung cancer--with special reference to surgical cases].
Fukami A
Igaku Kenkyu; 1984 Apr; 54(4):383-400. PubMed ID: 6099675
[No Abstract] [Full Text] [Related]
33. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
[TBL] [Abstract][Full Text] [Related]
34. Final results of a multicenter placebo-controlled levamisole study of resectable lung cancer.
Amery WK
Cancer Treat Rep; 1978 Nov; 62(11):1677-83. PubMed ID: 365323
[TBL] [Abstract][Full Text] [Related]
35. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
36. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
[TBL] [Abstract][Full Text] [Related]
37. [Effect of immunochemotherapy on the cases of advanced gastric cancer stage III].
Miwa H; Ono F; Kobayashi T; Orita K
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1735-41. PubMed ID: 6820882
[TBL] [Abstract][Full Text] [Related]
38. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of Adjuvant Immunochemotherapy Using OK-432 in Patients With Resected Non-Small-Cell Lung Cancer.
Sakamoto J; Teramukai S; Watanabe Y; Hayata Y; Okayasu T; Nakazato H; Ohashi Y
J Immunother (1991); 2001 May; 24(3):250-256. PubMed ID: 11395641
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
